Key result
MDM2 and CDK4 testing identifies lethal myxoid aortic intimal sarcoma mimicking benign thrombus.
Why the study?
Intimal sarcoma of the aorta is an extremely rare malignancy whose myxoid variant poses significant diagnostic challenges because its benign-appearing gross morphology and low FDG-PET uptake can mimic cardiac myxoma or organized thrombus.
Case Report (n=1)
No
Myxoid intimal sarcoma of the aorta can mimic benign thrombus or myxoma on FDG-PET and intraoperative frozen section, necessitating a high index of suspicion in patients with embolic complications and routine MDM2/CDK4 testing for accurate diagnosis.
May necessitate MDM2/CDK4 testing for embolic aortic masses despite benign FDG-PET and frozen section; leaves open refined preoperative diagnostic criteria.
Intimal sarcoma of the aorta is an extremely rare malignancy characterized by its intimal origin and poor prognosis. The myxoid variant poses significant diagnostic challenges due to its benign-appearing gross morphology and low FDG-PET uptake that can mimic cardiac myxoma or organized thrombus. We present a case of aortic intimal sarcoma that was misdiagnosed as thrombus based on imaging findings, highlighting the diagnostic pitfalls of this rare entity. A 69-year-old man presented with abdominal pain following cholecystectomy. Computed tomography revealed an intraluminal mass in the proximal descending thoracic aorta with embolic infarctions of the right kidney and spleen. FDG-PET demonstrated minimal uptake, suggesting thrombus rather than malignancy. Following recurrent embolic events including left popliteal artery occlusion, surgical resection was performed. Intraoperatively, the tumor appeared grossly consistent with benign myxoma, and frozen section analysis also returned a preliminary diagnosis of myxoma. However, final pathological examination revealed high-grade intimal sarcoma. Myxoid intimal sarcoma of the aorta can mimic benign pathology on both FDG-PET and gross examination. Clinicians should maintain a high index of suspicion for malignancy in aortic masses with embolic complications. Immunohistochemistry for MDM2/CDK4 should be performed to ensure accurate diagnosis even when imaging and macroscopic findings suggest benign pathology.
No takes yet. Share an insight, caveat, or question.
Hyun et al. (2026) conducted a case report in Myxoid intimal sarcoma of the descending thoracic aorta (n=1). En bloc surgical resection with prosthetic aortic graft replacement and MDM2/CDK4/FLI-1 immunohistochemical and FISH diagnostic profiling was evaluated on Definitive pathological diagnosis and postoperative overall survival. Myxoid aortic intimal sarcoma mimicked benign thrombus on FDG-PET (SUVmax 3.1) and myxoma on frozen section, requiring MDM2/CDK4 testing for diagnosis before death at 159 days post-resection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: